| |
| |
Have you checked out the INATE website?
INATE (INvestigators Against ThromboEmbolism) is an educational website that aims to improve the worldwide management of patients with venous thromboembolism (VTE). Started in 2001 by a Core Group of 12 investigators from various disciplines around the globe, it is an excellent source of information for both patients and professionals.
|
| |
|
|
|
| |
Content for site developed under the guidance of the TRACK Advisory Council.
|
|
 |
|
| |
 |
|
|
|
| |
Kenneth W. Mahaffey, MD |
Printer-friendly version |
| |
|
| |
| |
Kenneth W. Mahaffey, MD
|
|
Associate Professor of Medicine
Duke University Health System
Faculty, Director, Clinical Events Classification (CEC) Group
Duke Clinical Research Institute
Durham, North Carolina Kenneth Mahaffey joined the Duke Clinical Research Institute in 1996 after completing his cardiology fellowship at Duke and is currently an associate professor of medicine. His research focuses on anticoagulation in acute coronary syndromes, myocardial protection, and clinical trial methods. He has served as the principal or co-principal investigator for several significant cardiology trials in recent years, including CARDINAL, AMISTAD, and ATBAT. Dr Mahaffey is also the leader of the Duke Clinical Research Institute Clinical Events Classification (CEC) group. Under Dr Mahaffey’s leadership, the CEC group has become nationally recognized and has performed event adjudication for more than 25 large pivotal clinical trials in multiple therapeutic areas.
Dr Mahaffey is on the editorial board of Current Controlled Trials in Cardiovascular Medicine and the American Heart Journal. He is a fellow of the American College of Cardiology and a member of the Clinical Cardiology council of the American Heart Association. Dr Mahaffey is also a vice-chair of the Duke University Medical Center Institutional Review Board.
|
| |
|
|
| |
|
|